PlaqueTec, a Cambridge,UK-based company developing a biomarker-based approach to transform the understanding of coronary artery disease (CAD), the leading cause of death worldwide, has appointed Nick West as chief medical officer. Dr. West is a consultant interventional cardiologist at Papworth Hospital, Cambridge, the UK’s largest specialist cardiothoracic unit. He has worked with PlaqueTec for a number of years as medical advisor, and was principal investigator for both PlaqueTec’s recent c...